Article
Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology - 1 Feb 2010
Stirnimann Guido, Petitprez Séverine, Abriel Hugues, Schwick Nicola G
Abstract excerpt
A patient with an SCN5A p.W822X nonsense mutation, localized in the transmembrane region DII-S4 of the Na(v)1.5 sodium channel and leading to a non-expression of the mutant allele, was prescribed the selective serotonin reuptake inhibitor (SSRI) fluvoxamine (Floxyfral), 100 mg per day. His normal baseline ECG changed to a characteristic Brugada-Type-1-ECG pattern. To investigate whether fluvoxamine may reduce the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.